Fair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
23.0%/yr
±4.6% · revenue growth to justify current price
FCF-Based Reverse DCF
18.7%/yr
±3.1% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockAMETEK, Inc.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
AMETEK delivered record FY2025 sales (.4B, +6.6%), operating income, and EPS (.40, +7.9%) on organic growth (2%) + acquisition contribution (4%) + currency tailwind (1%). Strong backlog (.6B record) p...